Multicenter Prospective Validation of AI Models for Malignancy Risk Prediction in Pulmonary Nodules | MicrobiomeTrials← Back to trialsNCT07727122
Multicenter Prospective Validation of AI Models for Malignancy Risk Prediction in Pulmonary Nodules
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07Est. Completion: 2028-03
Enrollment target: 3,000 participants Locations- Second Affiliated Hospital of Army Medical University (Xinqiao Hospital), Chongqing, Chongqing Municipality, China
- Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
- Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
- Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
- Zhejiang University, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
Pulmonary Nodules
This is a very safe and beneficial clinical study. We hope to obtain near-real airway anatomical parameters of patients …
Multiple LocationsEst. completion Mar 2027
Pulmonary Nodules
Pulmonary nodule ablation is an established minimally invasive treatment for selected patients with pulmonary nodules. A…
Guangzhou, ChinaCompleted Jun 24, 2025